BioTime, Maruishi, Summit Pharmaceuticals deal

BTIM partner Summit granted Maruishi a sublicense to develop, manufacture and market BTIM's Hextend in Japan. In 2004, BTIM and Summit partnered to develop BTIM's Hextend and PentaLyte plasma extend...